Stock Analiz

Clover Health Investments, Corp. (CLOV) financials: revenue, earnings and cash flow

Fiscal 2019–2025 + TTM · from SEC filings · data as of November 13, 2026

Summary

Clover Health Investments’s revenue went from $462M in fiscal 2019 to $1.9B in fiscal 2025, growth of about 26.8% a year.

Net income in fiscal 2025 was -$86M, a net margin of -4.4%; the best year in this period was 2024 with -$43M.

Over the twelve months to September 30, 2026, revenue was $2.7B and net income $12M.

Free cash flow was -$69M in fiscal 2025 and positive in 1 of the 7 years shown.

The diluted share count rose 483% over the period (dilution).

Revenue, profit and cash flow by year

Revenue
2019: $462M20192020: $673M20202021: $1.5B20212022: $1.1B20222023: $1.3B20232024: $1.4B20242025: $1.9B2025$1.9B
Net income
2019: -$364M20192020: -$136M20202021: -$588M20212022: -$340M20222023: -$213M20232024: -$43M20242025: -$86M2025-$86M
Free cash flow
2019: -$160M20192020: -$119M20202021: -$283M20212022: -$208M20222023: -$145M20232024: $33M20242025: -$69M2025-$69M
EPS (diluted)
2019: $-4.1420192020: $-1.5420202021: $-1.4220212022: $-0.7120222023: $-0.4420232024: $-0.0920242025: $-0.172025$-0.17

Income statement

Fiscal yearTTM2025202420232022202120202019
Revenue$2.7B$1.9B$1.4B$1.3B$1.1B$1.5B$673M$462M
Gross profit———$257M$23M-$79M——
Operating income$12M-$86M-$46M-$205M-$287M-$637M-$93M-$183M
Net income$12M-$86M-$43M-$213M-$340M-$588M-$136M-$364M
EPS (diluted)$0.02$-0.17$-0.09$-0.44$-0.71$-1.42$-1.54$-4.14
R&D————————
Revenue growth—+40.3%+8.8%+15.0%−25.5%+118.8%+45.6%—

Cash flow

Fiscal yearTTM2025202420232022202120202019
Operating cash flow$135M-$67M$35M-$145M-$204M-$282M-$118M-$160M
Capital spending-$3M-$2M-$2M-$584000-$4M-$723000-$693000-$23000
Free cash flow$132M-$69M$33M-$145M-$208M-$283M-$119M-$160M
Dividends paid—$0$0$0$0$0$0$0
Buybacks$0$18M$2M$0$0$147000$0$0
Stock-based pay$54M$104M$114M$141M$164M$164M$7M$3M

Balance sheet

Fiscal yearTTM2025202420232022202120202019
Cash—$101M$222M$224M$293M$321M$92M—
Debt—$3M$3M$5M$6M$28M$138M—
Equity—$309M$341M$286M$348M$535M-$617M-$17631
Total assets—$541M$581M$571M$809M$951M$267M$100346
Shares (diluted)557M512M490M482M476M413M89M88M

Margins and returns

Fiscal yearTTM2025202420232022202120202019
Gross margin———20.4%2.1%-5.4%——
Operating margin0.5%-4.4%-3.3%-16.3%-26.1%-43.3%-13.8%-39.6%
Net margin0.5%-4.5%-3.1%-16.9%-31.0%-39.9%-20.3%-78.7%
FCF margin4.8%-3.6%2.4%-11.5%-19.0%-19.2%-17.7%-34.6%
ROIC—-27.4%-13.3%-70.5%-64.0%-89.3%——
ROE—-27.7%-12.6%-74.5%-97.7%-109.8%22.1%2063100.0%

Frequently asked questions

What is Clover Health Investments’s annual revenue?

$1.9B in fiscal 2025 and $2.7B over the twelve months to September 30, 2026.

How much profit does Clover Health Investments make?

Net income was -$86M in fiscal 2025 (net margin -4.4%).

Is Clover Health Investments’s revenue growing?

Yes: revenue rose 40.3% in fiscal 2025 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.